This analysis reveals improved survival in viral hepatocellular carcinoma, suggesting variations in therapeutic eligibility at recurrence.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kariyama et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: